Association between PCSK9 and LDLR gene polymorphisms with coronary heart disease: Case-control study and meta-analysis

• Published in: Clinical biochemistry Vol. 46; no. 9; pp. 727 - 732
• Main Authors: Zhang, Lina, Yuan, Fang, Liu, Panpan, Fei, Lijuan, Huang, Yi, Xu, Limin, Hao, Lingmei, Qiu, Xujun, Le, Yanping, Yang, Xi, Xu, Weifeng, Huang, Xiaoyan, Ye, Meng, Zhou, Jianqing, Lian, Jiangfang, Duan, Shiwei
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.06.2013
• Subjects: Aged; Case-Control Studies; Coronary Disease - genetics; Female; Gene Frequency; Genetic Association Studies; Genetic Predisposition to Disease; Genotype; Humans; LDL-C; LDLR; Male; Meta-analysis; Middle Aged; PCSK9; Polymorphism, Single Nucleotide; Proprotein Convertase 9; Proprotein Convertases - genetics; Receptors, LDL - genetics; Risk Factors; Sequence Analysis, DNA; Serine Endopeptidases - genetics; SNP; OR; LDL-C; CI; PCSK9; TC; Meta-analysis; HDL; TG; SNP; LDL; HWE; LDLR; CHD
• ISSN: 0009-9120; 1873-2933
• DOI: 10.1016/j.clinbiochem.2013.01.013

To explore the association of rs11206510 (PCSK9 gene) and rs1122608 (LDLR gene) polymorphisms with coronary heart disease (CHD) in Han Chinese. A total of 813 participants (290 CHD cases, 193 non-CHD controls and 330 healthy controls) were recruited in the case-control study. DNA genotyping was performed on the SEQUENOM® Mass–ARRAY iPLEX® platform. χ2-test was used to compare the genotype distribution and allele frequencies. Two meta-analyses were performed to establish the association between the two polymorphisms with CHD. No significant associations between the two SNPs and the risk of CHD were observed in the present study. The meta-analysis of rs11206510 of PCSK9 gene comprises 11 case-control studies with a total of 69,054 participants. Significant heterogeneity was observed in Caucasian population in subgroup analysis of the association studies of rs11206510 with CHD (P=0.003, I2=67.2%). The meta-analysis of LDLR gene rs1122608 polymorphism comprises 7 case-control studies with a total of 20,456 participants and the heterogeneity of seven studies was minimal (P=0.148, I2=36.7%). The results of the meta-analyses indicated that both SNPs were associated with CHD in Caucasians (P<0.05) but not in Asians. The results from our case-control study and meta-analyses might be explained by genetic heterogeneity in the susceptibility of CHD and ethnic differences between Asians and Caucasians. ► Association of rs11206510 and rs1122608 with CHD in 813 Chinese participants. ► The first association test of rs1122608 with the risk of CHD in Han Chinese. ► Meta-analyses were performed for rs11206510 and rs1122608. ► The two SNPs were associated with CHD in Caucasians but not in Asians.